340 related articles for article (PubMed ID: 15749281)
1. Discovery and development of biomarkers of neurological disease.
Dunckley T; Coon KD; Stephan DA
Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
[TBL] [Abstract][Full Text] [Related]
2. Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
Coon KD; Dunckley T; Stephan DA
Expert Rev Mol Diagn; 2004 May; 4(3):361-75. PubMed ID: 15137903
[TBL] [Abstract][Full Text] [Related]
3. Neuroproteomics: understanding the molecular organization and complexity of the brain.
Bayés A; Grant SG
Nat Rev Neurosci; 2009 Sep; 10(9):635-46. PubMed ID: 19693028
[TBL] [Abstract][Full Text] [Related]
4. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
6. Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.
Shoemaker LD; Achrol AS; Sethu P; Steinberg GK; Chang SD
Neurosurgery; 2012 Mar; 70(3):518-25. PubMed ID: 21866062
[TBL] [Abstract][Full Text] [Related]
7. Promises of biomarkers in drug development--a reality check.
Marrer E; Dieterle F
Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
[TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches in lung cancer biomarker development.
Cho JY; Sung HJ
Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
[TBL] [Abstract][Full Text] [Related]
9. Novel biomarkers of acute kidney toxicity.
Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery: validation and decision-making in product development.
Niedbala RS; Mauck C; Harrison P; Doncel GF
Sex Transm Dis; 2009 Mar; 36(3 Suppl):S76-80. PubMed ID: 19218888
[TBL] [Abstract][Full Text] [Related]
11. In biomarkers we trust?
Baker M
Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
[No Abstract] [Full Text] [Related]
12. Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery.
Isserlin R; Emili A
Curr Opin Mol Ther; 2008 Jun; 10(3):231-42. PubMed ID: 18535930
[TBL] [Abstract][Full Text] [Related]
13. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
15. Translation of neurological biomarkers to clinically relevant platforms.
Hayes RL; Robinson G; Muller U; Wang KK
Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
[TBL] [Abstract][Full Text] [Related]
16. Urinary proteomics--a tool for biomarker discovery.
Pejcic M; Stojnev S; Stefanovic V
Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
[TBL] [Abstract][Full Text] [Related]
17. Towards the application of proteomics in renal disease diagnosis.
Vidal BC; Bonventre JV; I-Hong Hsu S
Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
[TBL] [Abstract][Full Text] [Related]
18. New technologies for biomarker discovery in multiple sclerosis.
Comabella M; Racke MK
J Neuroimmunol; 2012 Jul; 248(1-2):1. PubMed ID: 22726889
[No Abstract] [Full Text] [Related]
19. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
20. Genomics and proteomics in process development: opportunities and challenges.
Gupta P; Lee KH
Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
